Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Sinusitis
Do you consider immunoglobulin replacement in a patient who has rapidly waning vaccine titers but does appropriately respond to revaccination?
Related Questions
When would you favor initiation of mepolizumab versus dupilumab for CRSwNP?
What treatment approach do you suggests for a patient with nasal polyp disease and asthma who was improved on dupilumab, but over last 2 years has begun to have increased nasal symptoms and rising eosinophil counts?
When do you consider extending the dosing interval for patients on biologics with CRSwNP?
How does acetaminophen serve as a preventive/lytic agent for hypersensitivity reactions if it is not in a class of anti-inflammatory drugs?
Do you recommend weekly SQ immunoglobulin replacement for an asplenic patient who only responded to 4/23 pneumococcal serotypes after the Prevnar 20 vaccine?
In a patient with HAE and on prophylaxis for HIV, who has failed Tazhyro and Orladeyo and breakthrough on Cinryze, what do you recommend for prophylaxis?
Is there any genetic testing available for the CDHR3 receptor?
Can a biopsy finding of eosinophilia in the gut (esophagus, stomach, duodenum) be reactive in the setting of Crohn's disease or due to anti-TNF blockade?
Have you experienced any issues with Alvesco inhalers getting clogged repeatedly?
What therapies would be considered safe and effective in pregnant patients with EoE?
